The BTLA‐TNFRSF14 signalling axis plays a key role in BPD pathogenesis, and blocking BTLA in mouse models reduces disease severity, suggesting potential therapeutic effects. This evidence concerns the gene BTLA and bronchopulmonary dysplasia.